What does DENDROGENIX do?

DENDROGENIX is a research organisation in Liège. Public Limited, started on 2 August 2018, 1 establishment.

What is the address of DENDROGENIX?

The registered office of DENDROGENIX is located at Avenue de l'Hôpital 11, 4000 Liège.

Is DENDROGENIX still active?

Yes. According to the CBE (29 October 2026) DENDROGENIX is active, legal situation “Normale toestand”, started on 2 August 2018.

Is DENDROGENIX registered on Peppol?

Yes, DENDROGENIX is registered on the Peppol network with ID 0208:0700613677.

What is the enterprise number of DENDROGENIX?

The enterprise number of DENDROGENIX is BE0700613677.

When was DENDROGENIX founded?

DENDROGENIX was founded on 2 August 2018.

Who are the directors of DENDROGENIX?

According to the 2025 annual accounts, the directors of DENDROGENIX are: Jean-Michel FOIDART, Philippe LEFEBVRE, SPARAXIS, NOSHAQ SPIN-OFFS SA, Stéphane SILVENTE, Jean COMBALBERT, Ingeborg HOCHMAIR, Emile LORIA.

Is DENDROGENIX a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 2 August 2018; 5 annual accounts filed, latest fiscal year 2025; 8 directors known from the annual account.

How much profit did DENDROGENIX make in 2025?

DENDROGENIX recorded a loss after taxes of € 2,293,770 in financial year 2025.

What is the revenue of DENDROGENIX?

As a small company, DENDROGENIX is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € -626,490.

How much does an employee at DENDROGENIX earn?

The average wage cost per full-time employee at DENDROGENIX was € 117,000 in 2025: staff costs of € 935,766 for 8 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does DENDROGENIX have?

According to the 2025 annual accounts, DENDROGENIX has 8 full-time equivalents (FTE).

DENDROGENIX (Public Limited) - Liège - BE0700613677

Dossier DENDROGENIX, printed on 29 October 2026 from databakkes.be/en/0700613677/dendrogenix. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Two loss years in a row NBB

Negative result in 2024 and 2025.
Shrinking team NBB

FTE fell two years in a row, from 11.6 to 8.

Financials

Financial year 2025

DENDROGENIX from Liège, company number BE0700613677, closed financial year 2025 with a result of € -2.3 million after tax. For that financial year DENDROGENIX recorded a gross margin of € -626,490 and equity of € 3.3 million. Compared with financial year 2024, the result moved from € -2.2 million to € -2.3 million. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 2, 2026.

What it is worth Healthy

€ 3.3 million

▼ 41% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -2.3 million

▼ 3 % more loss than in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 3.3 million

▲ 127% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € -2.2 million.

People and assets in 2025

Full-time equivalents

▼ 2.9 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 935,766

▼ 11% vs 2024

€ 117,000 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 2,330

▼ 56% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 361,404

▲ 58% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Wages and social charges

€ 97,414

▼ 47% vs 2024

Wages, holiday pay and social contributions still to pay. No outstanding taxes.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ -916,676 Gross margin 2022: € -916,676 First fiscal year in the series	€ -1,502,012 Gross margin 2023: € -1,502,012 ▼ € 585,336 vs 2022 (€ -916,676) Unfavourable step	€ -687,488 Gross margin 2024: € -687,488 ▲ € 814,525 vs 2023 (€ -1,502,012) Favourable step	€ -626,490 Gross margin 2025: € -626,490 ▲ € 60,997 vs 2024 (€ -687,488) Favourable step	▲ € 60,997
Profit after taxes	€ -3,524,068 Profit after taxes 2022: € -3,524,068 First fiscal year in the series	€ -2,835,612 Profit after taxes 2023: € -2,835,612 ▲ € 688,456 vs 2022 (€ -3,524,068) Favourable step	€ -2,223,089 Profit after taxes 2024: € -2,223,089 ▲ € 612,523 vs 2023 (€ -2,835,612) Favourable step	€ -2,293,770 Profit after taxes 2025: € -2,293,770 ▼ € 70,680 vs 2024 (€ -2,223,089) Unfavourable step	▼ € 70,680
Equity	€ 3,506,596 Equity 2022: € 3,506,596 First fiscal year in the series	€ 7,670,984 Equity 2023: € 7,670,984 ▲ 119% vs 2022 (€ 3,506,596) Favourable step	€ 5,590,720 Equity 2024: € 5,590,720 ▼ 27% vs 2023 (€ 7,670,984) Unfavourable step	€ 3,291,041 Equity 2025: € 3,291,041 ▼ 41% vs 2024 (€ 5,590,720) Unfavourable step	▼ 41%
Total debts	€ 1,031,731 Total debts 2022: € 1,031,731 First fiscal year in the series	€ 2,679,150 Total debts 2023: € 2,679,150 ▲ 160% vs 2022 (€ 1,031,731) Unfavourable step	€ 2,085,786 Total debts 2024: € 2,085,786 ▼ 22% vs 2023 (€ 2,679,150) Favourable step	€ 1,986,496 Total debts 2025: € 1,986,496 ▼ 5% vs 2024 (€ 2,085,786) Favourable step	▼ 5%
Cash	€ 2,831,160 Cash 2022: € 2,831,160 First fiscal year in the series	€ 7,313,556 Cash 2023: € 7,313,556 ▲ 158% vs 2022 (€ 2,831,160) Favourable step	€ 1,448,192 Cash 2024: € 1,448,192 ▼ 80% vs 2023 (€ 7,313,556) Unfavourable step	€ 3,288,997 Cash 2025: € 3,288,997 ▲ 127% vs 2024 (€ 1,448,192) Favourable step	▲ 127%
Retained profit	€ -7,364,733 Retained profit 2022: € -7,364,733 First fiscal year in the series	€ -2,835,612 Retained profit 2023: € -2,835,612 ▲ € 4.5 million vs 2022 (€ -7,364,733) Favourable step	€ 55,706 Retained profit 2024: € 55,706 ▲ € 2.9 million vs 2023 (€ -2,835,612) Favourable step	€ -2,238,064 Retained profit 2025: € -2,238,064 ▼ € 2.3 million vs 2024 (€ 55,706) Unfavourable step	▼ € 2.3 million
Balance sheet total	€ 4,538,327 Balance sheet total 2022: € 4,538,327 First fiscal year in the series	€ 10,350,134 Balance sheet total 2023: € 10,350,134 ▲ 128% vs 2022 (€ 4,538,327) Unchanged	€ 7,676,506 Balance sheet total 2024: € 7,676,506 ▼ 26% vs 2023 (€ 10,350,134) Unchanged	€ 5,277,538 Balance sheet total 2025: € 5,277,538 ▼ 31% vs 2024 (€ 7,676,506) Unchanged	▼ 31%
Employees (FTE)	8.2 Employees (FTE) 2022: 8.2 First fiscal year in the series	11.6 Employees (FTE) 2023: 11.6 ▲ 3.4 vs 2022 (8.2) Unchanged	10.9 Employees (FTE) 2024: 10.9 ▼ 0.7 vs 2023 (11.6) Unchanged	8 Employees (FTE) 2025: 8 ▼ 2.9 vs 2024 (10.9) Unchanged	▼ 2.9

Key figures of DENDROGENIX, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DENDROGENIX?

What happened at DENDROGENIX in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

2032 NOSHAQ SPIN-OFFS SA stepped down as director. NBB
2032 Stéphane SILVENTE stepped down as director. NBB
2030 Philippe LEFEBVRE stepped down as director. NBB
2030 Emile LORIA stepped down as director. NBB
2029 Jean COMBALBERT stepped down as director. NBB
2029 Ingeborg HOCHMAIR stepped down as director. NBB
2028 Jean-Michel FOIDART stepped down as director. NBB
2028 SPARAXIS stepped down as director. NBB

In short

From € 3.5 million loss in 2022 to € 2.3 million loss in 2025.

Original PDFs at the National Bank ↗

Management

NOSHAQ SPIN-OFFS 15.1%

Wallonie Entreprendre 10.1%

The stake of NOSHAQ SPIN-OFFS, Wallonie Entreprendre comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

DENDROGENIX

The shares are held by NOSHAQ SPIN-OFFS (15.1%) and Wallonie Entreprendre (10.1%).

Directors

According to the 2025 annual accounts

Jean-Michel FOIDART

Director

Also active at: BELMA TECHNOLOGIES

since 2022 · until 2028

Philippe LEFEBVRE

Director

Also active at: Fonds Léon Frédéricq pour la Promotion des Recherches médicales, fondamentales et cliniques, auprès du Centre HospitalierUniversitaire de Liège, Bridge2Health, ORL.Dr.P .LEFEBVRE

since 2024 · until 2030

SPARAXIS

Director · represented by FRANÇOISE JOSÉE THIELEN CAROLINE

Also active at: C.P. Bourg, A.M.B., Jean Goldschmidt International, Ateliers Pierre Cerfontaine, Floridienne, Fonderies J. Marichal Ketin et Cie, JUNGLING, MEBF +224 more

since 2022 · until 2028

NOSHAQ SPIN-OFFS SA

Director · represented by PATRICK ALAIN FRANCIS GHISLAIN STRAGIER

Also active at: SCIENCE PARK SERVICES, ARAPONICS

since 2026 · until 2032

Stéphane SILVENTE

Director

since 2026 · until 2032

Jean COMBALBERT

Director

since 2023 · until 2029

Ingeborg HOCHMAIR

Director

since 2023 · until 2029

Emile LORIA

Director

since 2024 · until 2030

Shareholders

NOSHAQ SPIN-OFFS

15.1%

Wallonie Entreprendre

10.1%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Avenue de l'Hôpital 11

4000 Liège

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 5 companies are registered at this address.

All companies at this address →

BELMA TECHNOLOGIES same network

€ 42,747 gross margin · 2025

LIVEDROP

€ -5,798 gross margin · 2025

OME-IT

€ 0 revenue · 2025

THAMEUS

€ -119,888 gross margin · 2025

HEPHAISTOS-BELGIUM

€ -98,146 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0700.613.677

VAT number

BE 0700.613.677

Registered office

Avenue de l'Hôpital 11, 4000 Liège

Names & denominations

DENDROGENIX

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

2 August 2018

Peppol

Active · Active since 31 Oct 2025

Activities · NACE

Speur- en ontwikkelingswerk op biotechnologisch gebied

Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied

View on CBE Public ↗ Annual accounts (NBB) ↗

DENDROGENIX

Warning lights

Financials

What happened to DENDROGENIX?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions